Frog Gut Bacterium Erased Tumors in Mice With a Single Dose
Japanese scientists isolated a bacterium from a tree frog's gut that wiped out colorectal tumors in every treated mouse with one intravenous dose, and the cancer never returned.
- A bacterium named Ewingella americana, isolated from a Japanese tree frog's gut, erased tumors in 100 percent of treated mice after a single intravenous dose.
- The disease never came back, and the bacterium outperformed both chemotherapy and immunotherapy.
- Inside the oxygen-starved tumor, the bacterium multiplies about 3,000 times in 24 hours, destroying cells and waking up the immune system.
- The result is in mice only, and human use is years of testing away.
Could a cancer treatment come out of a frog’s gut? It sounds made up, but Japanese scientists just published a paper claiming exactly that. One dose, one bacterium, and the tumor was gone in every mouse in the experiment.
The discovery comes from researchers at the Japan Advanced Institute of Science and Technology (JAIST). They named the bacterium Ewingella americana and found it in the gut of the Japanese tree frog (Dryophytes japonicus). The paper appeared on July 9 in the journal Gut Microbes. What sets it apart is not just the result, but how clean it is: the tumor was not shrunk or slowed, it was fully erased in all the animals, with no recurrence.
For context, the same bacterium outperformed two standard therapies in the same experiment. First chemotherapy, specifically doxorubicin. Then immunotherapy, an anti-PD-L1 antibody that has been a star of oncology in recent years. Both produced a weaker response than a single dose of the bacterium.
How Does One Bacterium Destroy a Whole Tumor?
The trick is that the tumor digs its own grave. The inside of a large tumor is starved of oxygen, because blood vessels cannot feed every cell. That is a nightmare for most drugs, but a perfect home for an anaerobic bacterium that dislikes oxygen anyway.
Ewingella americana works on two fronts. First, as an anaerobe, it piles up in exactly that oxygen-free part of the tumor, where healthy tissue keeps it out. There it multiplies about 3,000 times in just 24 hours. That population explosion directly tears tumor cells apart. The second front is the immune system: the presence of the bacterium wakes up the body’s defenses, which then attack the tumor themselves. So one blow crushes the cells, and the other calls in reinforcements.
That dual action is why researchers are not shrugging this off. Therapies that combine a direct attack with immune activation are what oncology has been chasing for years. Here it comes from a single organism, with no expensive genetic engineering, since the bacterium is in its natural form.
So Is a Treatment Coming Tomorrow?
No, and this is where honesty matters. Everything described happened in mice, under controlled laboratory conditions. A mouse is not a human, and cancer in people is more complex, slower and more varied. The history of medicine is full of therapies that erased tumors in rodents and then stumbled at the first serious clinical test.
Any eventual human use is years of testing away. Safety first, because injecting a live bacterium into the bloodstream carries its own risks and must be proven controllable. Then dosing, then efficacy across different tumor types, then comparison with existing therapies in real patients. Each of those steps can stop the whole story.
What remains is the direction. The idea that a microbe from an unexpected place, the gut of a frog, could be a weapon against cancer is not marketing, it is a preclinical result published in a peer-reviewed journal. That is worth watching, but without headlines that promise miracles.
Do you think bacteria will one day become a standard weapon against cancer, or is this another promise that will not survive clinical trials?
